FierceBiotechOriginal article
{"a":[{"_":"‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelics ","$":{"href":"/biotech/rising-tide-scenario-why-other-big-pharmas-could-follow-lilly-psychedelics","hreflang":"en"}}]}
Positive
AI Analysis
Summary
Eli Lilly acquired AtaiBeckley for $2.8 billion upfront, marking a significant entry into the psychedelics space that industry experts believe will drive momentum in the sector.
Importance:7/10
Sentiment:
0.60
acquisitionpsychedelicsbig pharmastrategic expansion
Related Companies
Read the original article
Published by FierceBiotech on July 18, 2026 9:40 AM
